Fund Holdings — Alphabet Inc.

Total Portfolio Value:
$2.58B
Total Bought:
$0
Total Sold:
$295.45M
Net Transaction:
-$295.45M
Securities
▲▼
SharesValue
Q3 2025
▲▼
Q4 2025
▲▼
Change
▲▼
Q3 2025
▲▼
Q4 2025
▲▼
Weight (%)
▲▼
Change
▲▼
AST SpaceMobile, Inc.CL A(ASTS)8,943,4868,943,4860$438.95M$649.57M25.18%+$210.62M
Planet Labs PBCCL A(PL)31,942,64131,942,6410$414.62M$629.91M24.42%+$215.29M
Revolution Medicines, Inc.(RVMD)4,133,2773,345,102-788,175$193.02M$266.44M10.33%+$73.41M
Arm Holdings PlcADS1,960,7841,960,7840$277.43M$214.33M8.31%-$63.10M
Freshworks Inc.CL A(FRSH)16,206,64316,206,6430$190.75M$198.53M7.70%+$7.78M
UiPath, Inc.CL A(PATH)7,034,3377,034,3370$94.12M$115.29M4.47%+$21.17M
GitLab Inc.CL A(GTLB)2,724,7122,724,7120$122.83M$102.26M3.96%-$20.57M
Tempus AI, Inc.CL A(TEM)1,551,1021,551,1020$125.19M$91.59M3.55%-$33.60M
DexCom, Inc.(DXCM)1,036,9371,036,9370$69.78M$68.82M2.67%-$954.0K
Maze Therapeutics, Inc.(MAZE)2,412,4711,388,583-1,023,888$62.56M$57.53M2.23%-$5.03M
Prime Medicine, Inc.(PRME)16,562,49816,562,4980$91.76M$57.47M2.23%-$34.28M
BridgeBio Oncology Therapeutics, Inc.(BBOT)2,823,1262,823,1260$32.69M$35.35M1.37%+$2.65M
Relay Therapeutics, Inc.(RLAY)1,568,7531,568,7530$8.19M$13.27M0.51%+$5.08M
Vera Therapeutics, Inc.CL A(VERA)241,264241,2640$7.01M$12.22M0.47%+$5.21M
Monte Rosa Therapeutics, Inc.(GLUE)1,464,015744,948-719,067$10.85M$11.68M0.45%+$832.4K
Sana Biotechnology, Inc.(SANA)2,812,5002,812,5000$9.98M$11.45M0.44%+$1.46M
Lyell Immunopharma, Inc.(LYEL)293,256293,2560$4.76M$9.03M0.35%+$4.26M
Beam Therapeutics Inc.(BEAM)321,604321,6040$7.81M$8.91M0.35%+$1.11M
Figma, Inc.CL A(FIG)215,582215,5820$11.18M$8.06M0.31%-$3.13M
Oscar Health, Inc.CL A(OSCR)481,988481,9880$9.12M$6.93M0.27%-$2.20M
GeneDx Holdings Corp.(WGS)22,71122,7110$2.45M$2.95M0.11%+$506.9K
Endeavour Silver Corp.(EXK)23,20523,2050$1.27M$2.36M0.09%+$1.09M
Spero Therapeutics, Inc.(SPRO)889,979889,9790$1.67M$2.07M0.08%+$400.5K
Autolus Therapeutics plcADS(AUTL)698,262698,2620$1.14M$1.39M0.05%+$251.4K
Hyperfine, Inc.CL A(HYPR)898,720898,7200$1.30M$880.7K0.03%-$422.4K
Tenaya Therapeutics, Inc.(TNYA)915,705915,7050$1.48M$650.2K0.03%-$833.3K
IRulya Therapeutics Inc.(IRLA)189,122189,1220$308.3K$633.6K0.02%+$325.3K
Fulcrum Therapeutics, Inc.(FULC)14,26214,2620$131.2K$161.3K0.01%+$30.1K
Repligen Corporation(RGEN)3833830$51.2K$62.8K0.00%+$11.6K
Alector Inc175,8660-175,866$520.6K$0—-$520.6K
Barinthus Biotherapeutics PlADS1,513,6440-1,513,644$1.89M$0—-$1.89M
Dianthus Therapeutics, Inc.(DNTH)208,6970-208,697$8.21M$0—-$8.21M
Foghorn Therapeutics Inc.(FHTX)500,9010-500,901$2.45M$0—-$2.45M
Fractyl Health, Inc.(GUTS)662,5840-662,584$1.05M$0—-$1.05M
Metsera Inc3,783,5280-3,783,528$197.99M$0—-$197.99M
Taysha Gene Therapies, Inc.(TSHA)640,8820-640,882$2.10M$0—-$2.10M
TScan Therapeutics, Inc.(TCRX)1,077,0800-1,077,080$1.96M$0—-$1.96M
Page 1 of 1
Alphabet Inc. — 13F Holdings — Q4 2025 | TickerTrail